PSG CEO, Piet Mouton says the fatality rate of Covid-19 pales in comparison to other causes of death in SA, like road fatalities.If the economy is not fully opened immediately, more people will die because of hardships if the economy, he said.Mouton said if government really cared about people, it would have used the money that…
SALT LAKE CITY — Utahns have enjoyed going shopping, eating out and worshiping together again. Many have returned to the office after months of working at home. Thousands have gathered for concerts or youth sporting events. But social interaction is coming at a price. COVID-19 cases and hospitalizations in Utah have surged since May 27,…
The buildings are being deep cleaned.Those who have learner and driving licence tests scheduled during the closure will be contacted.The Western Cape is home to 52.9% of those who have been infected with the novel coronavirus.Nine driving licence testing centres have been closed until further notice due to Covid-19, the City of Cape Town said…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f